~~<i id='87B3972D04'><strike id='87B3972D04'><tt id='87B3972D04'><pre id='87B3972D04'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

fashion

author：explore 2025-10-01 18:23:06 - browse：39718

Here at STAT, we spend a lot of time trying to imagine — and render — the invisible. We’ve gone inside of a developing embryo. We’ve flown inside our mouths to show the bacterial tribes that take root there. We’ve traveled through time and space to bring back to life a hallowed surgical theater. We’ve followed sound waves through our inner ears into our brains.

Of all of these fantastic journeys, one of the hardest subjects to capture, visually, has been CRISPR. Others have tried to capture the essence of the powerful gene-editing technique with the use of analogies.

Above, you can find our latest visual attempt to wrangle the genetic complexities of CRISPR into lively, and hopefully enjoyable, two minutes.

Previous article： The high cost of giving birth even with insurance
Next article： Bernie Sanders bashes nonprofit hospitals over their tax breaks

hotspot

knowledge

explore

hotspot

Foodmakersdon'twantregulatorstofocusonultra-processedfoodswhentheygotoupdatedietaryguidelines.DanKit

WSS

Wellcome Trust names Røttingen as its new CEO

Humana CEO Bruce Broussard to step down in 2024

A common UTI test for kids haunts adults as a traumatic 'nightmare'

European regulators consider appeal over Amylyx ALS drug

European regulators recommend Amylyx's ALS drug be rejected

How medical schools plan to diversify without affirmative action

focus

fashion

hotspot

Sports medicine is finally prioritizing gender equality

How doctors and nurses shape Google's AI

In Memoriam: Notable people who died in 2023

There’s no way to know how good AI health technologies are

Anesthesiologist group: stop taking Ozempic before surgery

Food makers tried to stack nutrition panel with preferred experts

Hepatitis C has a cure — but many Americans still lack access to it

What to make of Biden’s latest efforts on cancer research

Novavax promises a turnaround & Lilly roils the obesity market

Medicare to cover more brain scans related to Alzheimer’s drugs

knowledge

A fraught question for the kids of Alzheimer’s: Is it coming for us?

Life sciences deals on track to hit lowest point since 2017

FDA panel endorses Alnylam’s heart drug — after picking it apart

Will the IRA bring competition to the biologics market?

WATCH: Why do bright lights make us see spots?

What's changing in Medicare's open enrollment this year?

explore

hotspot

hotspot

hotspot